ChineseInvestors.com Inc. (CIIX) Subsidiary Featured in WSJ Report on China’s Growing Cannabis Industry
- ChineseInvestors.com is foremost financial information website for Chinese-speaking investors in U.S. and China
- CIIX subsidiary was featured in a recent Wall Street Journal report on China’s growing cannabis industry
- ChineseInvestors.com has highly diversified revenue streams that contribute to consistent, stable growth
ChineseInvestors.com Inc. (OTCQB: CIIX) offers an array of investor-education products and services and has become a top financial-information website for Chinese-speaking investors in the United States and China. At the heart of the approach is the ChineseInvestors Method, an inventive integration of a disciplined investing process, web-based tools, personalized instructions and support. In addition, the company is working to capitalize on the increasing demand for CBD (cannabidiol)-based nutrition and health products.
Established in 1999 and headquartered in San Gabriel, California, ChineseInvestors.com provides real-time market commentary, analysis and educational-related services in Chinese language character sets. In addition, CIIX offers consultative services to smaller private companies considering becoming a public company, as well as advertising and public-relations-related support services. Furthermore, the company provides retail, online and direct sales of hemp-based products and other health-related products.
Recently ChineseInvestors.com subsidiary, CBD Biotech Inc., was featured in a Wall Street Journal report on the growing cannabis industry in China (http://nnw.fm/ena9Q). The November 13 article was titled ‘China Says No to Marijuana but Lets Its Cannabis Industry Bloom’.
According to the WSJ report, “The CBD market will grow by 700% in the U.S. this year and will be worth more than $23 billion by 2023.” The report highlights CBD Biotech, which is a first mover in the industrial hemp skin-care and cosmetics industry. CBD Biotech is working to educate consumers on the benefits of industrial-hemp extract. Additionally, this subsidiary is also positioning itself to be one of the leaders in China’s legal market for skin-care products and cosmetics infused with cannabis sativa leaf extract, or industrial hemp extract. Cannabis sativa leaf extract can legally be added to skin-care and cosmetic products.
“As one of the first movers in the legal industrial hemp skin-care and cosmetics market, we are honored to be featured in this recent Wall Street Journal report and believe that this mention validates our efforts in China over the past few years,” CBD Biotech CEO Summer Yun stated in a news release.
ChineseInvestors.com has launched the world’s first online CBD health-products store published in the Chinese language: www.ChineseCBDOil.com. The company has done this under a wholesale agreement with a reputable CBD health brand. Through this website, the company sells CBD-infused products by way of online and in-store (http://nnw.fm/CA74n).
Overall, ChineseInvestors.com’s plan is to focus on its original mission of providing financial information and services to the larger Chinese community in the United States and elsewhere. Of note to investors regarding the company’s CBD initiatives is that ChineseInvestors.com CEO Warren Wang indicated that the company hopes for a Nasdaq IPO of CBD Biotech late in 2019 or early 2020 (http://nnw.fm/7ed0C). Following that, the company would concentrate on identifying an acquisition target for further growth. FinTech products and services and CBD initiatives contribute to the varied revenue streams of ChineseInvestors.com.
ChineseInvestors.com continues to help investors make informed investment decisions and meet their individual financial goals. The company is also at the vanguard of capitalizing on the convergence of CBD and the nutrition- and health-products market in mainland China. ChineseInvestors.com offers investors diverse revenue streams for potential portfolio growth.
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer